Insights

Funding & Restructuring Motif BioSciences has recently pursued financing rounds and restructuring activities to wind down parts of its business while advancing its iclaprim program. This presents an opportunity to offer cost-effective research, development, or licensing support, particularly for partners interested in late-stage or non-core assets.

Antibiotic Focus The core focus on iclaprim, a Gram-positive antibiotic, positions Motif BioSciences as a potential collaborator or customer for specialized antimicrobial manufacturing, regulatory consulting, and clinical trial services aimed at antibiotic programs and orphan or niche infectious disease indications.

Strategic Partnerships Recent partnerships, including in vivo preclinical studies with Lamellar Biomedical and CF lung infection research, indicate openness to collaboration on combination therapies and platform-enabled approaches, suggesting opportunities for joint development arrangements or technology licensing.

Executive & Advisory Addition of a non-executive director signals governance maturity and potential for strategic partnerships. Engage their leadership and advisory network for co-development deals, advisory services, or introductions to potential funders and industry collaborators.

Market Positioning Operating with a lean team and a revenue profile under one million, Motif BioSciences may seek collaboration to de-risk production, scale-up, and commercial strategy for antibiotic candidates, including potential tie-ins with manufacturing, distribution, or regional regulatory experts to accelerate timelines.

Similar companies to Motif BioSciences, Inc.

Motif BioSciences, Inc. Tech Stack

Motif BioSciences, Inc. uses 8 technology products and services including Drupal, WordPress, Font Awesome, and more. Explore Motif BioSciences, Inc.'s tech stack below.

  • Content Management System
  • Content Management System
  • Font Awesome
    Font Scripts
  • Infrastructure As A Service
  • Underscore.js
    Javascript Libraries
  • Platform As A Service
  • Real User Monitoring
  • System Analytics & Monitoring

Media & News

Motif BioSciences, Inc.'s Email Address Formats

Motif BioSciences, Inc. uses at least 1 email format:
Motif BioSciences, Inc. Email FormatsExamplePercentage
First.Last@motifbio.comJohn.Doe@motifbio.com
100%

Frequently Asked Questions

What is Motif BioSciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Motif BioSciences, Inc.'s official website is motifbio.com and has social profiles on LinkedIn.

How much revenue does Motif BioSciences, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Motif BioSciences, Inc.'s annual revenue is estimated to be <$1M.

What is Motif BioSciences, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Motif BioSciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Motif BioSciences, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Motif BioSciences, Inc. has approximately 1 employees across 1 continents, including North America. Key team members include Interim Chief Financial Officer: J. G. Explore Motif BioSciences, Inc.'s employee directory with LeadIQ.

What industry does Motif BioSciences, Inc. belong to?

Minus sign iconPlus sign icon
Motif BioSciences, Inc. operates in the Biotechnology industry.

What technology does Motif BioSciences, Inc. use?

Minus sign iconPlus sign icon
Motif BioSciences, Inc.'s tech stack includes Drupal, WordPress, Font Awesome, Google Cloud, Underscore.js, WP Engine, New Relic and Piwik.

What is Motif BioSciences, Inc.'s email format?

Minus sign iconPlus sign icon
Motif BioSciences, Inc.'s email format typically follows the pattern of First.Last@motifbio.com. Find more Motif BioSciences, Inc. email formats with LeadIQ.
Motif BioSciences, Inc. logo

Motif BioSciences, Inc.

BiotechnologyNew York, United States0-1 Employees

Motif BioSciences, Inc. is a biotechnology research company based in New York City, focused on developing novel antibiotic therapies. The firm operates in the field of clinical-stage biopharmaceuticals, with its work centered on compounds intended to treat bacterial infections, including those caused by Gram-positive organisms. Its activities are positioned within a niche of antimicrobial development, aiming to address unmet needs in infectious disease treatment.

Based in New York, Motif BioSciences engages in partnerships and preclinical collaborations, including work with external partners to evaluate antibiotic candidates and combinations. The company’s public profile reflects a small-scale operation within the biotechnology sector, with its location and described activities aligning with early-stage research and development within the broader pharmaceutical landscape.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
0-1

Section iconFunding & Financials

  • <$1M

    Motif BioSciences, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.